IVRAFERAV
Live / Registered — Registered (as of 17 Mar 2026)
What this means for you
Registered since 17 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98230485
- Registration number
- 8179179
- Mark type
- Stylized text
- Filed
- 19 Oct 2023
- Published for opposition
- 09 Jul 2024
- Registered
- 17 Mar 2026
- Attorney of record
- Angel Roman Campos
Goods and services
- Class 005 — Pharmaceuticals: Antiseptics; Biological preparations for the treatment of cancer; Human vaccine preparations; Immunostimulants; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Oral vaccine preparations; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations, namely, antivirals; Vaccine preparations; Vaccines; Viral vaccines
Owner
- IMMVIRA CO., LIMITED, Longhua Dist.,Shenzhen, CN
- IMMVIRA CO., LIMITED, Longhua Dist.,Shenzhen, CN
- IMMVIRA CO., LIMITED, Longhua Dist.,Shenzhen, CN
Prosecution history
- 17 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 17 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 24 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Aug 2025 — USE AMENDMENT FILED
- 20 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 15 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Feb 2025 — SOU EXTENSION 1 GRANTED
- 14 Feb 2025 — SOU EXTENSION 1 FILED
- 14 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION